Power morcellator for uterine fibroid removal not linked to cancer risk
the ONA take:
According to new findings published in the journal JAMA Oncology, researchers have found that the risk of bits of hidden cancerous tumors spreading throughout the abdomen when a power morcellator is used to remove fibroids in the uterus is low.
Before the U.S. Food and Drug Administration issued a black-box warning on the devices last November that the morcellator could spread and worsen an undetected cancerous uterine tumor, power morcellators were commonly used during minimally invasive surgery to remove uterine fibroids.
Uterine fibroids, which are non-cancerous growths in the uterine wall, are very common, but sometimes need to be removed when they cause pelvic pain and heavy menstrual bleeding. Treatment options include a hysterectomy to remove the uterus or surgery to remove the fibroids.
For the study, researchers identified 42,000 American women who had fibroids removed between 2006 and 2012, 3,200 of which were removed with power morcellators.
Of those, three were found to have uterine cancer, meaning the odds of developing uterine cancer after uterine fibroid removal was about 1 in 1,000 patients compared with 1 in 528 among women whose fibroid removal did not involve the power morcellators. The researchers note that the findings are reassuring.
Risk of bits of hidden cancerous tumors spreading throughout the abdomen when a power morecellator is used to remove fibroids in the uterus is low.
- Cabozantinib Activates Innate Immune Response, Eliminating Prostate Cancer
- Shorter Treatment of Breast Cancer with Trastuzumab May Lead to Improved Results
- Risk of Second Cancers Increased in Hodgkin Lymphoma Survivors
- Directly Informing Patients of Breast Cancer Risk, Options Improves Follow-Up Screening
- Kidney Cancer Metastases in Lung May Hide Undiagnosed Primary Lung Cancer
- Early Palliative Care Reduced ICU Use in Patients With Advanced Cancer
- Ginger Extract Raises Antioxidant Levels in Patients Undergoing Chemotherapy
- Nurse Navigators Improve Physician Engagement in Pretreatment Discussions
- Novel Blood Test Detects Cancer, Locates Tumor Without Invasive Procedures
- Screening Increases Early Palliative Care, Reduces Aggressive EOL Measures
- Mortality Rates Highest Among Youngest Oncology Patients, Particularly Minorities
- Survey Reveals Research Priorities for Cancer Patients, Oncology Nurses
- Smoking Increases Long-Term Risks From Radiotherapy in Breast Cancer
- Free Lung Cancer Screening Findings Support Continual Screenings in High-Risk Populations
- Parental Self-persuasion in Low-Income Groups Improves HPV Vaccination Rates
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|